{
    "nctId": "NCT05959811",
    "briefTitle": "Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients",
    "officialTitle": "Meridian Yoga on Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "CIPN - Chemotherapy-Induced Peripheral Neuropathy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Neuropathic Pain Scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Chinese or Taiwanese-proficient men and women aged \u226518 years.\n2. Patients with stage I-III breast cancer.\n3. Suffering from peripheral neuropathy caused by chemotherapy (professional judgment by a physician).\n4. Willing to adhere to requirement that no new pain medication be taken throughout the study period.\n5. Willing to adhere to all study-related procedures, including randomization to one of the two arms.\n6. Patient answers \"Yes\" to at least one factor in the question: \"Do participants think your balance, gait, posture, alignment, or flexibility has been affected by your experience of CIPN?\"\n\nExclusion Criteria:\n\n1. Metastatic disease.\n2. Drugs abuse such as amphetamines, morphine, etc.\n3. Pregnant\n4. Those with severe mental illness or mental instability who cannot cooperate with the trial.\n5. People who are severely hearing impaired, visually impaired, or demented and unable to perform yoga.\n6. Severe heart disease or chronic obstructive lung disease, liver or kidney failure,and edema or severe skin damage.\n7. Severe spinal disease, affecting actors.\n8. Those who have participated in yoga practice in the past month.\n9. Those who do not sign the informed consent.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}